2021年2月8日:全国新增确诊病例14例,均为境外输入病例(上海7例,广东7例);新增无症状感染者16例(境外输入15例)

2021-02-08 网络 网络

根据中国国家卫健委最新通报,2月7日0—24时,31个省(自治区、直辖市)和新疆生产建设兵团报告新增确诊病例14例,均为境外输入病例(上海7例,广东7例);无新增死亡病例;无新增疑似病例。

根据中国国家卫健委最新通报,2月7日0—24时,31个省(自治区、直辖市)和新疆生产建设兵团报告新增确诊病例14例,均为境外输入病例(上海7例,广东7例);无新增死亡病例;无新增疑似病例。

截至2月7日24时,据31个省(自治区、直辖市)和新疆生产建设兵团报告,现有确诊病例1118例(其中重症病例20例),累计治愈出院病例83952例,累计死亡病例4636例,累计报告确诊病例89706例,现有疑似病例3例。累计追踪到密切接触者971472人,尚在医学观察的密切接触者27636人。

31个省(自治区、直辖市)和新疆生产建设兵团报告新增无症状感染者16例(境外输入15例);当日无转为确诊病例;当日解除医学观察59例(境外输入8例);尚在医学观察无症状感染者639例(境外输入291例)。

2月7日,青田新增一例境外输入新冠肺炎复阳案例。经调查,该病例于2020年12月25日在上海被诊断为境外输入确诊病例,并经隔离治疗治愈后出院。2月4日从上海包车出发,抵达青田后直接进行集中隔离。2月7日因血压高,由救护车去人民医院进行检查就诊,检测新冠病毒核酸阳性。发现该病例后,青田县第一时间启动应急预案迅速落实应急措施。目前,患者已在县定点医院隔离治疗,对县人民医院、集中隔离点等场所进行了全面终末消毒。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1949054, encodeId=88491949054dc, content=<a href='/topic/show?id=311793e585f' target=_blank style='color:#2F92EE;'>#输入病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93758, encryptionId=311793e585f, topicName=输入病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Wed May 26 03:37:52 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353311, encodeId=b64713533115f, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 09 23:37:52 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485158, encodeId=24f7148515832, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 09 23:37:52 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923609, encodeId=50f2923609f2, content=春运时期,尤其要注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Mon Feb 08 09:14:57 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923608, encodeId=bf8d923608f2, content=😂, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erib0mOUtfroRJ2PSxgaTNt0P2K0VfiaxnpBag1pfnn7wictd9lf5jRyUFCJ98qafica6EqWxbCDJibhIw/132, createdBy=b3ed5306253, createdName=苏磊, createdTime=Mon Feb 08 09:03:51 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923602, encodeId=020892360268, content=看到了,注意!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/686fa813d9f7423a8f4eb8d95ffa18dc/2e4411e44b9c4d0db82bc22975780aa8.jpg, createdBy=f18a2482420, createdName=metal分析, createdTime=Mon Feb 08 08:41:56 CST 2021, time=2021-02-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1949054, encodeId=88491949054dc, content=<a href='/topic/show?id=311793e585f' target=_blank style='color:#2F92EE;'>#输入病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93758, encryptionId=311793e585f, topicName=输入病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Wed May 26 03:37:52 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353311, encodeId=b64713533115f, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 09 23:37:52 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485158, encodeId=24f7148515832, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 09 23:37:52 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923609, encodeId=50f2923609f2, content=春运时期,尤其要注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Mon Feb 08 09:14:57 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923608, encodeId=bf8d923608f2, content=😂, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erib0mOUtfroRJ2PSxgaTNt0P2K0VfiaxnpBag1pfnn7wictd9lf5jRyUFCJ98qafica6EqWxbCDJibhIw/132, createdBy=b3ed5306253, createdName=苏磊, createdTime=Mon Feb 08 09:03:51 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923602, encodeId=020892360268, content=看到了,注意!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/686fa813d9f7423a8f4eb8d95ffa18dc/2e4411e44b9c4d0db82bc22975780aa8.jpg, createdBy=f18a2482420, createdName=metal分析, createdTime=Mon Feb 08 08:41:56 CST 2021, time=2021-02-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1949054, encodeId=88491949054dc, content=<a href='/topic/show?id=311793e585f' target=_blank style='color:#2F92EE;'>#输入病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93758, encryptionId=311793e585f, topicName=输入病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Wed May 26 03:37:52 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353311, encodeId=b64713533115f, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 09 23:37:52 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485158, encodeId=24f7148515832, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 09 23:37:52 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923609, encodeId=50f2923609f2, content=春运时期,尤其要注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Mon Feb 08 09:14:57 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923608, encodeId=bf8d923608f2, content=😂, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erib0mOUtfroRJ2PSxgaTNt0P2K0VfiaxnpBag1pfnn7wictd9lf5jRyUFCJ98qafica6EqWxbCDJibhIw/132, createdBy=b3ed5306253, createdName=苏磊, createdTime=Mon Feb 08 09:03:51 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923602, encodeId=020892360268, content=看到了,注意!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/686fa813d9f7423a8f4eb8d95ffa18dc/2e4411e44b9c4d0db82bc22975780aa8.jpg, createdBy=f18a2482420, createdName=metal分析, createdTime=Mon Feb 08 08:41:56 CST 2021, time=2021-02-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1949054, encodeId=88491949054dc, content=<a href='/topic/show?id=311793e585f' target=_blank style='color:#2F92EE;'>#输入病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93758, encryptionId=311793e585f, topicName=输入病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Wed May 26 03:37:52 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353311, encodeId=b64713533115f, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 09 23:37:52 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485158, encodeId=24f7148515832, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 09 23:37:52 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923609, encodeId=50f2923609f2, content=春运时期,尤其要注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Mon Feb 08 09:14:57 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923608, encodeId=bf8d923608f2, content=😂, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erib0mOUtfroRJ2PSxgaTNt0P2K0VfiaxnpBag1pfnn7wictd9lf5jRyUFCJ98qafica6EqWxbCDJibhIw/132, createdBy=b3ed5306253, createdName=苏磊, createdTime=Mon Feb 08 09:03:51 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923602, encodeId=020892360268, content=看到了,注意!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/686fa813d9f7423a8f4eb8d95ffa18dc/2e4411e44b9c4d0db82bc22975780aa8.jpg, createdBy=f18a2482420, createdName=metal分析, createdTime=Mon Feb 08 08:41:56 CST 2021, time=2021-02-08, status=1, ipAttribution=)]
    2021-02-08 飞翔的乌龟

    春运时期,尤其要注意

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1949054, encodeId=88491949054dc, content=<a href='/topic/show?id=311793e585f' target=_blank style='color:#2F92EE;'>#输入病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93758, encryptionId=311793e585f, topicName=输入病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Wed May 26 03:37:52 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353311, encodeId=b64713533115f, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 09 23:37:52 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485158, encodeId=24f7148515832, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 09 23:37:52 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923609, encodeId=50f2923609f2, content=春运时期,尤其要注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Mon Feb 08 09:14:57 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923608, encodeId=bf8d923608f2, content=😂, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erib0mOUtfroRJ2PSxgaTNt0P2K0VfiaxnpBag1pfnn7wictd9lf5jRyUFCJ98qafica6EqWxbCDJibhIw/132, createdBy=b3ed5306253, createdName=苏磊, createdTime=Mon Feb 08 09:03:51 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923602, encodeId=020892360268, content=看到了,注意!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/686fa813d9f7423a8f4eb8d95ffa18dc/2e4411e44b9c4d0db82bc22975780aa8.jpg, createdBy=f18a2482420, createdName=metal分析, createdTime=Mon Feb 08 08:41:56 CST 2021, time=2021-02-08, status=1, ipAttribution=)]
    2021-02-08 苏磊

    😂

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1949054, encodeId=88491949054dc, content=<a href='/topic/show?id=311793e585f' target=_blank style='color:#2F92EE;'>#输入病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93758, encryptionId=311793e585f, topicName=输入病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Wed May 26 03:37:52 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353311, encodeId=b64713533115f, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 09 23:37:52 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485158, encodeId=24f7148515832, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 09 23:37:52 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923609, encodeId=50f2923609f2, content=春运时期,尤其要注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Mon Feb 08 09:14:57 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923608, encodeId=bf8d923608f2, content=😂, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erib0mOUtfroRJ2PSxgaTNt0P2K0VfiaxnpBag1pfnn7wictd9lf5jRyUFCJ98qafica6EqWxbCDJibhIw/132, createdBy=b3ed5306253, createdName=苏磊, createdTime=Mon Feb 08 09:03:51 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923602, encodeId=020892360268, content=看到了,注意!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/686fa813d9f7423a8f4eb8d95ffa18dc/2e4411e44b9c4d0db82bc22975780aa8.jpg, createdBy=f18a2482420, createdName=metal分析, createdTime=Mon Feb 08 08:41:56 CST 2021, time=2021-02-08, status=1, ipAttribution=)]
    2021-02-08 metal分析

    看到了,注意!

    0

相关资讯

2021年2月6日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿586万,全球疫苗接种量超过感染总数,中国接种速度开始加快

Worldometers世界实时统计数据显示,截至北京时间2021年2月6日7时24分,全球累计确诊新冠肺炎(COVID-19)病例超过10586万例,新增458,405例,达到105,864,287

世卫组织:全球新冠疫苗接种量已超新冠肺炎感染者总数

当地时间2月5日,世卫组织举行新冠肺炎例行发布会,世卫组织总干事谭德塞表示,全球新冠疫苗接种量已超新冠肺炎感染者总数,在如此短的时间内取得了令人瞩目的成就,这是一个好消息。

2021年2月7日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿586万,全球疫苗接种量超过感染总数,中国接种速度开始加快

Worldometers世界实时统计数据显示,截至北京时间2021年2月7日7时24分,全球累计确诊新冠肺炎(COVID-19)病例超过10632万例,新增415,730例,达到106,321,240

2021年2月7日:新增确诊新冠肺炎病例11例 其中本土病例1例

据国家卫健委网站消息,2月6日0—24时,31个省(自治区、直辖市)和新疆生产建设兵团报告新增确诊病例11例,其中境外输入病例10例(上海3例,北京2例,江苏2例,广东2例,湖南1例),本

Lancet Rheumato: 重症新冠肺炎:白介素抑制可用,但不能都用!

如何用白介素抑制剂治疗重度新冠肺炎患者?

2021年2月8日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿667万,疫情呈现明显拐点

Worldometers世界实时统计数据显示,截至北京时间2021年2月8日8时20分,全球累计确诊新冠肺炎(COVID-19)病例超过10667万例,新增343,068例,达到106,672,809